GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 31, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Epilepsy
Interventions
DRUG

GW273225

Trial Locations (30)

14226

GSK Clinical Trials Call Center, Amherst

21287

GSK Clinical Trials Call Center, Baltimore

23219

GSK Clinical Trials Call Center, Richmond

24018

GSK Clinical Trials Call Center, Roanoke

27560

GSK Clinical Trials Call Center, Durham

32209

GSK Clinical Trials Call Center, Jacksonville

32308

GSK Clinical Trials Call Center, Tallahassee

33613

GSK Clinical Trials Call Center, Tampa

43614

GSK Clinical Trials Call Center, Toledo

44195

GSK Clinical Trials Call Center, Cleveland

52242

GSK Clinical Trials Call Center, Iowa City

55905

GSK Clinical Trials Call Center, Rochester

56303

GSK Clinical Trials Call Center, Saint Cloud

60612

GSK Clinical Trials Call Center, Chicago

62704

GSK Clinical Trials Call Center, Springfield

63310

GSK Clinical Trials Call Center, St Louis

65804

GSK Clinical Trials Call Center, Springfield

67214

GSK Clinical Trials Call Center, Wichita

72205

GSK Clinical Trials Call Center, Little Rock

75230

GSK Clinical Trials Call Center, Dallas

85054

GSK Clinical Trials Call Center, Phoenix

85351

GSK Clinical Trials Call Center, Sun City

90404

GSK Clinical Trials Call Center, Santa Monica

95128

GSK Clinical Trials Call Center, San Jose

97225

GSK Clinical Trials Call Center, Portland

97504

GSK Clinical Trials Call Center, Medford

98104

GSK Clinical Trials Call Center, Seattle

02215

GSK Clinical Trials Call Center, Boston

97239-3098

GSK Clinical Trials Call Center, Portland

05401

GSK Clinical Trials Call Center, Burlington

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00567424 - GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures | Biotech Hunter | Biotech Hunter